M&A Deal Summary |
|
---|---|
Date | 2006-12-11 |
Target | Celmed BioSciences |
Sector | Life Science |
Buyer(s) | Kiadis Pharma |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Kiadis Pharma is a clinical stage biopharmaceutical company pioneering a proprietary cell-based, personalized therapy for patients with blood cancers and related disorders, an area of significant unmet medical need.Kiadis Pharma’s unique and powerful platform technology has led to an initial experimental product, ATIR™, which has already been clinically tested on sixty patients. Kiadis Pharma is based in Amsterdam, Netherlands.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
Country (Canada) | 1 of 1 |
Year (2006) | 1 of 1 |